Polygenic Risk Scores

In partnership with

The LED Device Clinics Trust.

Thousands of medical and aesthetic professionals rely on Celluma Light Therapy for one reason: it delivers consistent, clinically validated results.

Celluma devices are FDA-cleared for wrinkles, acne, pain relief, hair growth, and body contouring — more indications than any other at-home LED brand offers.

The difference isn’t appearance. It’s engineering.

Precise wavelengths. Optimized power density. Processor-driven treatment modes. And a patented flexible design that conforms closely to your face, scalp, or body for uniform light delivery.

Clinical study participants experienced a 66% reduction in wrinkles, and a 76% improvement in acne after four weeks of consistent use. There are over 4,000 published studies confirming the effectiveness of red & near-infrared light therapy on musculoskeletal conditions.

No gimmicks. No shortcuts.

Just professional-grade photobiomodulation — now available in the comfort of your home.

If you want the serious version of light therapy, this is it.

Get up to $300 off Celluma

_{Results vary. Consistency required. FDA-cleared for specific indications.}

Genetics has long been associated with rare, single‑gene disorders, but polygenic risk scores (PRS) are expanding the field into everyday medicine. PRS combine the influence of thousands of genetic variants to estimate an individual’s risk for common conditions like heart disease, breast cancer, and type 2 diabetes.

The power of PRS lies in personalization. Two patients with identical cholesterol levels may have dramatically different genetic risk profiles — and therefore different preventive needs. Clinicians are beginning to use PRS to guide screening intervals, lifestyle recommendations, and even medication decisions.

However, the science is still evolving. PRS accuracy varies across ethnic groups, and interpretation requires careful communication to avoid anxiety or misunderstanding. Still, as datasets grow more diverse and models improve, PRS are poised to become a routine part of primary care.

The future of prevention will be shaped not just by what patients do, but by what their genomes quietly predict.